大理学院学报
大理學院學報
대이학원학보
JOURNAL OF DALI COLLEGE
2014年
8期
45-46
,共2页
李剑波%杜月娥%刁丽波%蔡云玲%叶文华%梁艳娇%何永勋
李劍波%杜月娥%刁麗波%蔡雲玲%葉文華%樑豔嬌%何永勛
리검파%두월아%조려파%채운령%협문화%량염교%하영훈
Rh(D)阴性血型%表现型%不规则抗体
Rh(D)陰性血型%錶現型%不規則抗體
Rh(D)음성혈형%표현형%불규칙항체
Rh(D)negative blood type%phenotype%irregular antibody
目的:了解大理州无偿献血者Rh(D)阴性血型的血清学表现型及不规则抗体存在情况。方法:检测献血者样本136803例,采用血清学方法确证Rh表现型,使用抗人球蛋白试剂对不规则抗体作筛查。结果:确证Rh(D)阴性献血者209例(0.15%);其中含不规则抗体1例(0.48%),血清学表现型中:ccdee 123例(58.85%),Ccdee 67例(32.06%),CCdee 7例(3.35%), ccdEe 6例(2.87%),CcdEe 5例(2.39%),CCdEe 1例(0.48%)。该阴性献血者ABO血型分布情况A>O>B>AB。结论:对献血者Rh(D)阴性血型的血清学表现型及不规则抗体作检测,将有利于为临床安全及时有效输血提供保障。
目的:瞭解大理州無償獻血者Rh(D)陰性血型的血清學錶現型及不規則抗體存在情況。方法:檢測獻血者樣本136803例,採用血清學方法確證Rh錶現型,使用抗人毬蛋白試劑對不規則抗體作篩查。結果:確證Rh(D)陰性獻血者209例(0.15%);其中含不規則抗體1例(0.48%),血清學錶現型中:ccdee 123例(58.85%),Ccdee 67例(32.06%),CCdee 7例(3.35%), ccdEe 6例(2.87%),CcdEe 5例(2.39%),CCdEe 1例(0.48%)。該陰性獻血者ABO血型分佈情況A>O>B>AB。結論:對獻血者Rh(D)陰性血型的血清學錶現型及不規則抗體作檢測,將有利于為臨床安全及時有效輸血提供保障。
목적:료해대리주무상헌혈자Rh(D)음성혈형적혈청학표현형급불규칙항체존재정황。방법:검측헌혈자양본136803례,채용혈청학방법학증Rh표현형,사용항인구단백시제대불규칙항체작사사。결과:학증Rh(D)음성헌혈자209례(0.15%);기중함불규칙항체1례(0.48%),혈청학표현형중:ccdee 123례(58.85%),Ccdee 67례(32.06%),CCdee 7례(3.35%), ccdEe 6례(2.87%),CcdEe 5례(2.39%),CCdEe 1례(0.48%)。해음성헌혈자ABO혈형분포정황A>O>B>AB。결론:대헌혈자Rh(D)음성혈형적혈청학표현형급불규칙항체작검측,장유리우위림상안전급시유효수혈제공보장。
Objective:To investigate serological phenotype and to detect irregular antibody among Rh(D)negative blood donors in Dali Prefecture. Methods: 136 803 blood samples were detected to determine the Rh phenotypes through serological tests and the irregular antibodies were screened through antiglobulin tests. Results: 209 blood samples were Rh (D) negative (0.15%). The irregular antibodies were found in one Rh(D)negative sample(0.48%). The serological phenotypes included 123 ccdee(58.85%), 67 Ccdee(32.06%), 7 CCdee(3.35%), 6 ccdEe(2.87%), 5 CcdEe(2.39%)and 1 CcdEe(0.48%). Among all Rh(D)negative volunteer blood donors, the distribution of A, B, O and AB blood types was A>O>B>AB. Conclusion: The study of serological phenotype and irregular antibody of Rh(D)negative blood donors would be helpful for enhancing the clinical safety and timely blood transfusion.